Ilyang Pharmaceutical Co.,Ltd (KRX:007570)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,050
+10 (0.08%)
At close: Sep 10, 2025
-0.08%
Market Cap 233.92B
Revenue (ttm) 276.09B
Net Income (ttm) 15.91B
Shares Out 17.92M
EPS (ttm) 886.59
PE Ratio 14.72
Forward PE n/a
Dividend 150.00 (1.15%)
Ex-Dividend Date Dec 29, 2025
Volume 22,452
Average Volume 19,099
Open 13,040
Previous Close 13,040
Day's Range 12,950 - 13,150
52-Week Range 9,540 - 15,490
Beta 0.62
RSI 54.62
Earnings Date Nov 13, 2025

About KRX:007570

Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and be... [Read more]

Sector Healthcare
Founded 1946
Employees 666
Stock Exchange Korea Stock Exchange
Ticker Symbol 007570
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.